T 2019/14 of 22.09.2015
- European Case Law Identifier
- ECLI:EP:BA:2015:T201914.20150922
- Date of decision
- 22 September 2015
- Case number
- T 2019/14
- Online on
- 30 September 2015
- Petition for review of
- -
- Application number
- 09175437.4
- IPC class
- G01N 33/577C12P 21/08C12N 15/13C07K 16/00C12N 15/63C07K 16/24A61P 43/00A61K 39/395C12N 5/10
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Human antibodies that bind human IL-12 and methods for producing
- Applicant name
- AbbVie Deutschland GmbH & Co KG
- Opponent name
- Janssen Biotech, Inc./Opposition withdrawn
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 108European Patent Convention R 101(1)
- Keywords
- Missing statement of grounds
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is rejected as inadmissible.